Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes
AssigneeRibonomics, Inc.
InventorsJack D. Keene, Scott A. Tenenbaum, Craig C. Carson
Life of this patent
Estimating the term…
Loading patent…
AssigneeRibonomics, Inc.
InventorsJack D. Keene, Scott A. Tenenbaum, Craig C. Carson
Estimating the term…
Cellular mRNA-protein (mRNP) complexes are partitioned in vivo by contacting a biological sample with at least one ligand that specifically binds at least one component of a mRNP complex. Suitable biological samples comprise at least one mRNA-protein (mRNP) complex and include cell cultures, cell extracts, and whole tissue, including tumor tissue. Ligands include antibodies that specifically bind RNA-binding or RNA-associated proteins present in the mRNP complex. The mRNP complex is separated by binding the ligand with a binding molecule specific for the ligand, where the binding molecule is attached to a solid support. The mRNP complex is collected by removing the mRNP complex from the solid support. After collecting the mRNP complex, the mRNA bound within the complex may be characterized and identified. Subsets of the total mRNA population of a cell may accordingly be characterized, and a gene expression profile of the cell obtained.
A method of generating a gene expression profile of mRNA in a cell in vivo, comprising the steps of:
A method of generating a gene expression profile of the mRNA in a cell in vivo comprising the steps of:
Dependencies are inferred from the claim text.